Exosome in Alzheimer's Disease
Exosomes produced by mesenchymal stem cells (MSCs) have demonstrated neuroprotective qualities. In clinical settings, these exosomes can enhance cognitive performance and slow the accumulation of amyloid-β plaques, a hallmark of Alzheimer's disease. This suggests that exosome-based therapies might offer a viable option for halting or even reversing Alzheimer's progression.